Indian drugmaker Wockhardt Ltd <WCKH.NS> will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca <AZN.L> and Oxford University, it said on Monday.
The company has reserved fill-and-finish capacity - the final manufacturing step of putting vaccines into vials or syringes and packaging them - as part of an agreement with the UK government, it said.
Shares in Wockhardt jumped 10% after the news in a downcast Mumbai market. [.BO]
The UK government has also reserved one fill-and-finish production line at a Wockhardt subsidiary in Wrexham, Wales for its exclusive use for the next 18 months to secure supply.
More than 150 vaccines are being developed and tested around the world to stop the pandemic, with 25 in human clinical trials, according to the World Health Organization.
Coronavirus cases globally have crossed 18 million, including more than 688,000 deaths.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
"Like A Dictator In High Heels...": Bombshell Report On Meghan Markle Meta To Start Using Public Posts On Facebook, Instagram In UK To Train AI UK PM In US For Talks With Joe Biden On Ukraine Missile Use Against Russia 9 Dead, 2,800 Hurt As Pagers Explode Across Lebanon, Hezbollah Blames Israel IndiGo Flight Tailstrike Leaves Huge Dent During Take-Off From Delhi Airport Highlights: Arvind Kejriwal Resigns, Atishi To Be Delhi Chief Minister Kamala Harris Calls For End To War In Gaza, No Israeli Reoccupation Kamala Harris Dials Trump After Apparent Assassination Attempt Ghislaine Maxwell's Sex-Trafficking Conviction Upheld, Appeal Planned Track Latest News Live on NDTV.com and get news updates from India and around the world.